These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 28262777)

  • 41. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel therapeutic approaches for diabetic nephropathy and retinopathy.
    Usuelli V; La Rocca E
    Pharmacol Res; 2015 Aug; 98():39-44. PubMed ID: 25447794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetic nephropathy: an inherited disease or just a diabetic complication?
    Berger M; Mönks D; Wanner C; Lindner TH
    Kidney Blood Press Res; 2003; 26(3):143-54. PubMed ID: 12886042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
    Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
    Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diabetic nephropathy - current concepts in early diagnosis and treatment of diabetic microvascular complications].
    Meier M; Haller H
    Herz; 2004 Aug; 29(5):496-503. PubMed ID: 15340735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetic nephropathy.
    Boner G; Cooper ME
    Diabetes Technol Ther; 1999; 1(4):489-96. PubMed ID: 11474836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis of diabetic nephropathy.
    Raptis AE; Viberti G
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S424-37. PubMed ID: 11460589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation.
    Berger SP; Roos A; Mallat MJ; Schaapherder AF; Doxiadis II; van Kooten C; Dekker FW; Daha MR; de Fijter JW
    J Am Soc Nephrol; 2007 Aug; 18(8):2416-22. PubMed ID: 17634432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidney involvement and disease in patients with diabetes.
    Chiarelli F; Trotta D; Verrotti A; Mohn A
    Panminerva Med; 2003 Mar; 45(1):23-41. PubMed ID: 12682618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitors of the complement system currently in development for cardiovascular disease.
    Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS
    Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Transcriptome Array-Based Approach to Link SGLT-2 and Intrarenal Complement C5 Synthesis in Diabetic Nephropathy.
    Korsten P; Tampe B
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.
    Papadopoulou-Marketou N; Chrousos GP; Kanaka-Gantenbein C
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27457509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nephropathy in type 1 diabetes.
    Marre M
    Semin Vasc Med; 2002 Feb; 2(1):97-107. PubMed ID: 16222600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of triglyceride-rich lipoproteins in diabetic nephropathy.
    Rutledge JC; Ng KF; Aung HH; Wilson DW
    Nat Rev Nephrol; 2010 Jun; 6(6):361-70. PubMed ID: 20440276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Agents in development for the treatment of diabetic nephropathy.
    Fukami K; Cooper ME; Forbes JM
    Expert Opin Investig Drugs; 2005 Mar; 14(3):279-94. PubMed ID: 15833059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetic kidney disease and immune modulation.
    Hickey FB; Martin F
    Curr Opin Pharmacol; 2013 Aug; 13(4):602-12. PubMed ID: 23721739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of complement in diabetes.
    Ajjan RA; Schroeder V
    Mol Immunol; 2019 Oct; 114():270-277. PubMed ID: 31400630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of diabetic nephropathy.
    Chowdhury TA; Barnett AH; Bain SC
    Trends Endocrinol Metab; 1996 Nov; 7(9):320-3. PubMed ID: 18406765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Mechanisms of Diabetic Kidney Disease.
    Rico-Fontalvo J; Aroca G; Cabrales J; Daza-Arnedo R; Yánez-Rodríguez T; Martínez-Ávila MC; Uparella-Gulfo I; Raad-Sarabia M
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.